Updated Trabecular Bone Score accounting for the soft tissue thickness (TBS TT) demonstrated significantly improved bone microstructure with Denosumab in the FREEDOM TBS post hoc analysis

Updated Trabecular Bone Score accounting for the soft tissue thickness (TBS TT) demonstrated significantly improved bone microstructure with Denosumab in the FREEDOM TBS post hoc analysis

Abstract:

Summary: TBS algorithm has been updated to account for regional soft tissue noise. In postmenopausal women with osteoporosis, denosumab improved tissue thickness–adjusted TBS vs placebo independently of bone mineral density over 3 years, with the magnitude of changes from baseline or placebo numerically greater than body mass index–adjusted TBS.

Conclusion: In postmenopausal women with osteoporosis, denosumab significantly improved bone microstructure assessed by TBS TT vs placebo and demonstrated greater magnitude of improvement compared to the classical BMI adjustment.